Abstract Toxic cardiomyopathies include those caused by drug abuse, as well as chemotherapy agents. This review addresses cardiomyopathies induced by alcoholism, amphetamines, and anabolic steroids, focusing on their pathophysiology, clinical presentation, treatment, and prognosis. Alcoholic cardiomyopathy is frequent and predominates in males. It is dose-dependent, with a probable genetic predisposition. Women are susceptible at lower doses of alcohol intake. The disease ranges from a subclinical asymptomatic form to the typical form of dilated cardiomyopathy with systolic dysfunction and heart failure […]